$VRCA

Verrica Pharmaceuticals Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Medicinal and Botanical Manufacturing

PRICE

$2.615 ▲4.6%

Delayed Price

VOLUME

285,348

DAY RANGE

-

52 WEEK

1.77 - 14.79

Join Discuss about VRCA with like-minded investors

profile
@dros #droscrew
recently

Upgrades 5/25: $APD $CME $EQH $FANG $KRC $MMP $MOLN $SBRA $UNVR . Downgrades 5/25: $ASGN $BBY $CVET $DVN $EPRT $FSR $PHG $TWOU $URBN $VRCA $WIT

57 Replies 7 👍 11 🔥

Key Metrics

Market Cap

68.80 M

Beta

0.91

Avg. Volume

437.94 K

Shares Outstanding

27.52 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-10

Next Dividend Date

Company Information

Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica's late-stage product candidate, VP-102, is in development to treat molluscum contagiosum (molluscum), common warts and external genital warts, three of the largest unmet needs in medical dermatology. Verrica is also developing VP-103, its second cantharidin-based product candidate, for the treatment of plantar warts. The Company has also entered a worldwide license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic oncology conditions.

CEO: Ted White

Website:

HQ: 10 N High St Ste 200 West Chester, 19380-3014 Pennsylvania

Related News